Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Medline Inc. before investing.

In this article, we go over a few key elements for understanding Medline Inc.’s stock price such as:

• Medline Inc.’s current stock price and volume
• Why Medline Inc.’s stock price changed recently
• Upgrades and downgrades for MDLN from analysts
• MDLN’s stock price momentum as measured by its relative strength

About Medline Inc. (MDLN)

Before we jump into Medline Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon’s gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Want to learn more about Medline Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medline Inc..

Medline Inc.’s Stock Price as of Market Close

As of September 11, 2026, 4:00 PM, CST, Medline Inc.’s stock price was $32.530.

Medline Inc. is up 0.43% from its previous closing price of $32.390.

During the last market session, Medline Inc.’s stock traded between $31.870 and $32.920. Currently, there are approximately 856.67 million shares outstanding for Medline Inc..

Medline Inc.’s price-earnings (P/E) ratio is currently at 40.9, which is high compared to the Health Care Equipment & Supplies industry median of 25.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Medline Inc. Stock Price History

Medline Inc.’s (MDLN) price is currently down 7.14% so far this month.

During the month of September, Medline Inc.’s stock price has reached a high of $36.980 and a low of $31.870.

Over the last year, Medline Inc. has hit prices as high as $50.876 and as low as $31.870. Year to date, Medline Inc.’s stock is down 22.55%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Medline Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 11, 2026, there was 1 analyst who downgraded Medline Inc.’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Medline Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Medline Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Medline Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medline Inc. (MDLN) by visiting AAII Stock Evaluator.

Relative Price Strength of Medline Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 11, 2026, Medline Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Medline Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Medline Inc. Stock Price: Bottom Line

As of September 11, 2026, Medline Inc.’s stock price is $32.530, which is up 0.43% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Medline Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.